European Union | Immunization, DPT (% of children ages 12-23 months)
Child immunization, DPT, measures the percentage of children ages 12-23 months who received DPT vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against diphtheria, pertussis (or whooping cough), and tetanus (DPT) after receiving three doses of vaccine. Development relevance: Immunization is one of the most cost-effective public health interventions, and ??is an essential component for reducing under-five mortality. Immunization coverage estimates are used to monitor coverage of immunization services and to guide disease eradication and elimination efforts. Limitations and exceptions: In many developing countries a lack of precise information on the size of the cohort of one-year-old children makes immunization coverage difficult to estimate from program statistics. Statistical concept and methodology: Governments in developing countries usually finance immunization against measles and diphtheria, pertussis (whooping cough), and tetanus (DTP) as part of the basic public health package. The data shown here are based on an assessment of national immunization coverage rates by the WHO and UNICEF. The assessment considered both administrative data from service providers and household survey data on children's immunization histories. Based on the data available, consideration of potential biases, and contributions of local experts, the most likely true level of immunization coverage was determined for each year. Notes on regional and global aggregates: When the vaccine is not introduced in a national immunization schedule, the missing value is assumed zero (or close to zero) in the relevant groups' averages.
Publisher
The World Bank
Origin
European Union
Records
63
Source
European Union | Immunization, DPT (% of children ages 12-23 months)
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
44.87506314 1980
61.41363908 1981
63.20111742 1982
63.70308534 1983
74.22429797 1984
76.62053978 1985
80.35210854 1986
77.06790083 1987
77.086392 1988
79.33945671 1989
88.52168433 1990
90.94440751 1991
91.2663144 1992
86.29106032 1993
90.77152665 1994
91.81500947 1995
93.09970876 1996
93.81951145 1997
93.97453885 1998
95.67679027 1999
93.84506928 2000
95.34219998 2001
95.61216736 2002
96.76831244 2003
96.36301472 2004
96.33018455 2005
96.97080866 2006
96.91614401 2007
96.93635559 2008
96.59926191 2009
96.93134499 2010
96.61270899 2011
96.86973917 2012
96.49851213 2013
96.11329152 2014
95.33121539 2015
94.70784717 2016
94.07704216 2017
94.13109494 2018
94.32265 2019
93.44895176 2020
93.1369282 2021
93.04235231 2022
European Union | Immunization, DPT (% of children ages 12-23 months)
Child immunization, DPT, measures the percentage of children ages 12-23 months who received DPT vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against diphtheria, pertussis (or whooping cough), and tetanus (DPT) after receiving three doses of vaccine. Development relevance: Immunization is one of the most cost-effective public health interventions, and ??is an essential component for reducing under-five mortality. Immunization coverage estimates are used to monitor coverage of immunization services and to guide disease eradication and elimination efforts. Limitations and exceptions: In many developing countries a lack of precise information on the size of the cohort of one-year-old children makes immunization coverage difficult to estimate from program statistics. Statistical concept and methodology: Governments in developing countries usually finance immunization against measles and diphtheria, pertussis (whooping cough), and tetanus (DTP) as part of the basic public health package. The data shown here are based on an assessment of national immunization coverage rates by the WHO and UNICEF. The assessment considered both administrative data from service providers and household survey data on children's immunization histories. Based on the data available, consideration of potential biases, and contributions of local experts, the most likely true level of immunization coverage was determined for each year. Notes on regional and global aggregates: When the vaccine is not introduced in a national immunization schedule, the missing value is assumed zero (or close to zero) in the relevant groups' averages.
Publisher
The World Bank
Origin
European Union
Records
63
Source